Evaluation of the Immunological and Hematological parameters of Systemic Lupus Erythematosus in Iraqi Women

rana mohsen; rana mohsen; Haneen Z. Al-Taee; Wafaa Hussien Habeeb; Anmar Kamil

doi:10.32792/utq/utjsci/v11i2.1267

Authors

rana mohsen anbar univercity
rana mohsen
Haneen Z. Al-Taee
Wafaa Hussien Habeeb
Anmar Kamil

DOI:

https://doi.org/10.32792/utq/utjsci/v11i2.1267

Abstract

Systemic lupus erythematosus is an autoimmune disease involving several systems, mainly affects young adult women, and causes a significant deterioration in quality of life. Different environmental aspects are known to facilitate the development of lupus in predisposed individuals. Hemoglobin concentration (HB), granulocyte level, hemoglobin level, saturation (ESR), and platelets (PLT) were among the clinical blood indicators that were found to be associated with the beginning of SLE in adults and teenagers. Blood PLT levels in both SLE patients were significantly lower than in the G1 control group (P< 0.001). When compared to the control group, G1, the two SLE patient groups (G2 & G3) had noticeably higher ESRs (P < 0.01). The study employed many immunological markers, such as C-reactive protein (CRP), antinuclear antibody (ANA), Anti-double stranded DNA (Anti-dsDNA), complement components C3 and C4 levels. Serum CRP levels were significantly higher in G2 and G3 SLE patients (P<0.001) than in the G1 control group. Research revealed that two SLE patient groups (G2 & G3) had blood levels of ANA and Anti-double stranded DNA (Anti-dsDNA) that were considerably higher than those of the control group (G1).

Received: 2024-06-03

Revised: 2024-06-19

Accepted: 2024-07-7

References

[1] Y. You, X. Zhao, Y. Wu, J. Mao, L. Ge, J. Guo, et al., "Integrated transcriptome profiling revealed that elevated long non-coding RNA-AC007278. 2 expression repressed CCR7 transcription in systemic lupus erythematosus," Frontiers in Immunology, vol. 12, p. 615859, 2021.

M. R. Barber, C. Drenkard, T. Falasinnu, A. Hoi, A. Mak, N. Y. Kow, et al., "Global epidemiology of systemic lupus erythematosus," Nature Reviews Rheumatology, vol. 17, pp. 515-532, 2021.

O. Zharkova, T. Celhar, P. D. Cravens, A. B. Satterthwaite, A.-M. Fairhurst, and L. S. Davis, "Pathways leading to an immunological disease: systemic lupus erythematosus," Rheumatology, vol. 56, pp. i55-i66, 2017.

S. Ryu, W. Fu, and M. A. Petri, "Associates and predictors of pleurisy or pericarditis in SLE," Lupus science & medicine, vol. 4, p. e000221, 2017.

Z. A. Al-Sarray, I. A. Al-Rayahi, A. H. Al-Hafidh, and A. T. Dwayyikh, "Serum Protein Electrophoresis in Iraqi Systemic lupus Erythematous Patient," Al-Nisour Journal for Medical Sciences, vol. 2, pp. 34-46, 2020.

A. Bengtsson and L. Rönnblom, "Systemic lupus erythematosus: still a challenge for physicians," Journal of internal medicine, vol. 281, pp. 52-64, 2017.

C. Mok and C. Lau, "Pathogenesis of systemic lupus erythematosus," Journal of clinical pathology, vol. 56, pp. 481-490, 2003.

G. Stojan and M. Petri, "Epidemiology of systemic lupus erythematosus: an update," Current opinion in rheumatology, vol. 30, pp. 144-150, 2018.

A. Duarte-García, M. Hocaoglu, S.-A. Osei-Onomah, J. Y. Dabit, R. E. Giblon, C. G. Helmick, et al., "Population-based incidence and time to classification of systemic lupus erythematosus by three different classification criteria: a Lupus Midwest Network (LUMEN) study," Rheumatology, vol. 61, pp. 2424-2431, 2022.

M. Barbhaiya and K. H. Costenbader, "Environmental exposures and the development of systemic lupus erythematosus," Current opinion in rheumatology, vol. 28, pp. 497-505, 2016.

E. C. Somers, W. Marder, P. Cagnoli, E. E. Lewis, P. DeGuire, C. Gordon, et al., "Population‐based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program," Arthritis & rheumatology, vol. 66, pp. 369-378, 2014.

M. Housey, P. DeGuire, S. Lyon-Callo, L. Wang, W. Marder, W. J. McCune, et al., "Incidence and prevalence of systemic lupus erythematosus among Arab and Chaldean Americans in southeastern Michigan: the Michigan Lupus Epidemiology and Surveillance Program," American journal of public health, vol. 105, pp. e74-e79, 2015.

A. M. ELAMIR, A. A. FARID, E. S. AMIN, H. A. HASSAN, M. M. MAGED, and A. A. AREF, "Anti-nuclear antibody (ANA) patterns in egyptian systemic lupus erythematosus," Journal of the Egyptian Society of Parasitology, vol. 49, pp. 451-454, 2019.

R. Wichainun, N. Kasitanon, S. Wangkaew, S. Hongsongkiat, W. Sukitawut, and W. Louthrenoo, "Sensitivity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: a comparison using control sera obtained from healthy individuals and patients with multiple medical problems," Asian Pacific journal of allergy and immunology, vol. 31, p. 292, 2013.

T. Gheita, N. Abaza, N. Hammam, A. Mohamed, I. El-Gazzar, and A. Eissa, "Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies," Lupus, vol. 27, pp. 1081-1087, 2018.

G. Waris and K. Alam, "Immunogenicity of superoxide radical modified-DNA: studies on induced antibodies and SLE anti-DNA autoantibodies," Life sciences, vol. 75, pp. 2633-2642, 2004.

X. Song, H. Huang, Y. Liu, Y. Zhao, S. Li, and Z. Xu, "Coexistence of sarcoidosis and primary Sjögren syndrome: A clinical analysis and literature review," Zhonghua nei ke za zhi, vol. 56, pp. 375-377, 2017.

Z.-C. Liu and Q.-L. Zhou, "Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis," Inflammation research, vol. 61, pp. 277-284, 2012.

C. Qu, J. Zhang, X. Zhang, J. Du, B. Su, and H. Li, "Value of combined detection of anti‑nuclear antibody, anti‑double‑stranded DNA antibody and C3, C4 complements in the clinical diagnosis of systemic lupus erythematosus," Experimental and Therapeutic Medicine, vol. 17, pp. 1390-1394, 2019.

E. Littlejohn, W. Marder, E. Lewis, S. Francis, J. Jackish, W. J. McCune, et al., "The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever," Lupus, vol. 27, pp. 1123-1129, 2018.

M. Aringer, "Inflammatory markers in systemic lupus erythematosus," Journal of autoimmunity, vol. 110, p. 102374, 2020.

L. M. Vilá, G. S. Alarcón, G. McGwin, H. M. Bastian, B. J. Fessler, J. D. Reveille, et al., "Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual," The Journal of rheumatology, vol. 32, pp. 2150-2155, 2005.

G. Bharath, P. Kumar, N. Makkar, P. Singla, M. Soneja, A. Biswas, et al., "Mortality in systemic lupus erythematosus at a teaching hospital in India: A 5-year retrospective study," Journal of Family Medicine and Primary Care, vol. 8, pp. 2511-2515, 2019.

E. Esmaeilzadeh, Z. Khodamoradi, and M. Nazarinia, "One-decade study of distinct features, morbidity and mortality of systemic lupus erythematosus (an update on systemic lupus erythematosus in the Fars Province of Iran)," Lupus, vol. 28, pp. 1360-1367, 2019.

N. Jiang, M. Li, M. Zhang, J. Xu, L. Jiang, L. Gong, et al., "Chinese SLE Treatment and Research group (CSTAR) registry: clinical significance of thrombocytopenia in Chinese patients with systemic lupus erythematosus," PLoS One, vol. 14, p. e0225516, 2019.

J. Wang, R. Niu, L. Jiang, Y. Wang, X. Shao, M. Wu, et al., "The diagnostic values of C-reactive protein and procalcitonin in identifying systemic lupus erythematosus infection and disease activity," Medicine, vol. 98, p. e16798, 2019.

Evaluation of the Immunological and Hematological parameters of Systemic Lupus Erythematosus in Iraqi Women

Authors

DOI:

Abstract

References

Published

Issue

Section

Categories

License

How to Cite

Make a Submission

Information

Indexing and Archiving

_{Sherpa Romeo}

Journal Information

Browse